| Title: |
« L’IA va révolutionner la filière du médicament ». |
| Authors: |
Lavie, Frédéric1 |
| Source: |
Actulabo. 2/12/2025, Issue 473, p7-7. 1p. |
| Subject Terms: |
*Artificial intelligence, *Simulation methods & models, Biological systems, Drug development, Clinical trials |
| Geographic Terms: |
France |
| Abstract (English): |
The director of innovation and research at Leem discusses the impact of AI on the pharmaceutical industry at the AI Summit. AI allows for the simulation of biological systems, accelerates drug development, and reduces the number of patients needed for clinical trials. France is well positioned in health AI, but must continue to progress to maintain its advantage. [Extracted from the article] |
| Abstract (French): |
Le directeur de l'innovation et de la recherche du Leem discute de l'impact de l'IA sur la filière du médicament lors du Sommet de l'IA. L'IA permet de simuler des systèmes biologiques, d'accélérer le développement de médicaments et de réduire le nombre de patients nécessaires aux essais cliniques. La France est bien positionnée dans l'IA santé, mais doit continuer à progresser pour maintenir son avantage. [Extracted from the article] |
|
Copyright of Actulabo is the property of MCM Presse and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Business Source Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
